MYL2 and familial dilated cardiomyopathy: S15 and S14/S15 of myosin light chain 2 (Myl2) in human and mouse, respectively, are critical regulatory phosphorylation sites targeted by myosin light chain kinase in which their reduced phosphorylation associates with DCM and heart failure via impacts on cross-bridge cycling kinetics and contractile force36.